Paul Swerdlow

3.8k total citations
64 papers, 2.6k citations indexed

About

Paul Swerdlow is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Paul Swerdlow has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Genetics, 32 papers in Hematology and 18 papers in Molecular Biology. Recurrent topics in Paul Swerdlow's work include Hemoglobinopathies and Related Disorders (43 papers), Iron Metabolism and Disorders (21 papers) and Blood groups and transfusion (10 papers). Paul Swerdlow is often cited by papers focused on Hemoglobinopathies and Related Disorders (43 papers), Iron Metabolism and Disorders (21 papers) and Blood groups and transfusion (10 papers). Paul Swerdlow collaborates with scholars based in United States, United Kingdom and Italy. Paul Swerdlow's co-authors include Kenneth I. Ataga, Samir K. Ballas, Wally R. Smith, Abdullah Kutlar, Myron A. Waclawiw, Oswaldo Castro, Daniel Finley, William F. McCarthy, Martin H. Steinberg and Laura DeCastro and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Paul Swerdlow

64 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Swerdlow United States 29 1.4k 1.2k 816 391 293 64 2.6k
James S. Nichols United States 21 1.7k 1.2× 1.2k 1.0× 608 0.7× 261 0.7× 651 2.2× 39 2.9k
Fred Lorey United States 31 717 0.5× 629 0.5× 776 1.0× 1.1k 2.8× 303 1.0× 78 2.9k
George R. Honig United States 25 839 0.6× 659 0.6× 1.1k 1.3× 391 1.0× 484 1.7× 91 2.6k
Annalisa Castagna Italy 32 586 0.4× 912 0.8× 1.3k 1.6× 107 0.3× 185 0.6× 100 3.2k
Hirofumi Kobayashi Japan 36 454 0.3× 1.7k 1.4× 2.0k 2.5× 114 0.3× 217 0.7× 113 4.2k
Michele Caggana United States 31 404 0.3× 264 0.2× 1.1k 1.4× 477 1.2× 615 2.1× 135 3.3k
Mary Ann Knovich United States 15 492 0.3× 907 0.8× 341 0.4× 64 0.2× 123 0.4× 28 2.0k
Nalini Raghavachari United States 30 392 0.3× 416 0.4× 1.6k 2.0× 125 0.3× 757 2.6× 66 3.4k
Yaddanapudi Ravindranath United States 41 648 0.5× 2.7k 2.3× 1.5k 1.9× 1.1k 2.9× 440 1.5× 180 5.5k
Martine Ropert France 22 960 0.7× 1.3k 1.1× 231 0.3× 83 0.2× 205 0.7× 93 2.0k

Countries citing papers authored by Paul Swerdlow

Since Specialization
Citations

This map shows the geographic impact of Paul Swerdlow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Swerdlow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Swerdlow more than expected).

Fields of papers citing papers by Paul Swerdlow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Swerdlow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Swerdlow. The network helps show where Paul Swerdlow may publish in the future.

Co-authorship network of co-authors of Paul Swerdlow

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Swerdlow. A scholar is included among the top collaborators of Paul Swerdlow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Swerdlow. Paul Swerdlow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bumma, Naresh, et al.. (2017). Scheduled Outpatient Red Blood Cell Exchange Program Reduces Admission and Complications in Sickle Cell Disease. Blood. 130. 3536–3536. 1 indexed citations
2.
Jordan, Lanetta, Paul Swerdlow, & Thomas D. Coates. (2013). Systematic Review of Transition From Adolescent to Adult Care in Patients With Sickle Cell Disease. Journal of Pediatric Hematology/Oncology. 35(3). 165–169. 58 indexed citations
3.
Swerdlow, Paul, et al.. (2012). Hypogonadism in Patients with Sickle Cell Disease: Central or Peripheral?. Acta Haematologica. 128(2). 65–68. 39 indexed citations
4.
Meiler, Steffen E., Marlene Wade, F. Kutlar, et al.. (2011). Pomalidomide augments fetal hemoglobin production without the myelosuppressive effects of hydroxyurea in transgenic sickle cell mice. Blood. 118(4). 1109–1112. 61 indexed citations
5.
Smith, Wally R., Samir K. Ballas, William F. McCarthy, et al.. (2011). The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients. Pain Medicine. 12(5). 697–705. 28 indexed citations
6.
Vichinsky, Elliott, Kwaku Ohene‐Frempong, Clarisse Lopes de Castro Lobo, et al.. (2010). Transfusion and Chelation Practices in Sickle Cell Disease: A Regional Perspective. Pediatric Hematology and Oncology. 28(2). 124–133. 19 indexed citations
7.
Steinberg, Martin H., William F. McCarthy, Oswaldo Castro, et al.. (2010). The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: A 17.5 year follow‐up. American Journal of Hematology. 85(6). 403–408. 353 indexed citations
8.
Bao, Bin, Ananda S. Prasad, Frances W.J. Beck, et al.. (2008). Zinc supplementation decreases oxidative stress, incidence of infection, and generation of inflammatory cytokines in sickle cell disease patients. Translational research. 152(2). 67–80. 143 indexed citations
9.
Vichinsky, Elliott, Zahra Pakbaz, Onyinye Onyekwere, et al.. (2008). Patient-Reported Outcomes of Deferasirox (Exjade®, ICL670) versus Deferoxamine in Sickle Cell Disease Patients with Transfusional Hemosiderosis. Acta Haematologica. 119(3). 133–141. 55 indexed citations
10.
Ibrahim, R., Chin Liu, Simon Cronin, et al.. (2007). Drug Removal by Plasmapheresis: An Evidence‐Based Review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(11). 1529–1549. 83 indexed citations
11.
Ballas, Samir K., Franca B. Barton, Myron A. Waclawiw, et al.. (2006). Hydroxyurea and sickle cell anemia: effect on quality of life. Health and Quality of Life Outcomes. 4(1). 59–59. 123 indexed citations
12.
Nelson, Dorothy A., et al.. (2003). Trabecular and Integral Bone Density in Adults with Sickle Cell Disease. Journal of Clinical Densitometry. 6(2). 125–129. 30 indexed citations
13.
Brown, Steven, James R. Ewing, Tavarekere N. Nagaraja, et al.. (2003). Sickle red blood cells accumulate in tumor. Magnetic Resonance in Medicine. 50(6). 1209–1214. 10 indexed citations
14.
Al‐Sukhun, Sana, et al.. (2000). Pulmonary hypertension is present in 10-30% of adult patients with sickle cell disease. Blood. 96. 4 indexed citations
15.
Prasad, Ananda S., Frances W.J. Beck, Joseph Kaplan, et al.. (1999). Effect of zinc supplementation on incidence of infections and hospital admissions in sickle cell disease (SCD). American Journal of Hematology. 61(3). 194–202. 98 indexed citations
16.
Swerdlow, Paul, Eugene P. Orringer, & Donald J. Abraham. (1992). A Reply Dietary Management of Sickle Cell Anaemia with Vanillin. Free Radical Research Communications. 17(5). 351–352. 2 indexed citations
17.
Ellis, Amy, Roderick T. Bunch, Joyce K. Randolph, et al.. (1992). Components of intrinsic drug resistance in the rat hepatoma. Biochemical Pharmacology. 43(2). 331–342. 8 indexed citations
18.
Swerdlow, Paul, et al.. (1990). A Conserved Sequence in Histone H2A Which Is a Ubiquitination Site in Higher Eucaryotes Is Not Required for Growth in Saccharomyces cerevisiae. Molecular and Cellular Biology. 10(9). 4905–4911. 7 indexed citations
19.
Scott, Robert B., et al.. (1990). Simultaneous measurement of neutrophil, lymphocyte, and monocyte glutathione by flow cytometry. Journal of Clinical Laboratory Analysis. 4(5). 324–327. 16 indexed citations
20.
Perrine, Susan P., et al.. (1989). Butyric Acid Modulates Developmental Globin Gene Switching in Man and Sheep. Advances in experimental medicine and biology. 271. 177–183. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James S. Nichols Breakdown of academic impact, for papers by Fred Lorey Breakdown of academic impact, for papers by George R. Honig Breakdown of academic impact, for papers by Annalisa Castagna Breakdown of academic impact, for papers by Hirofumi Kobayashi Breakdown of academic impact, for papers by Michele Caggana Breakdown of academic impact, for papers by Mary Ann Knovich Breakdown of academic impact, for papers by Nalini Raghavachari Breakdown of academic impact, for papers by Yaddanapudi Ravindranath Breakdown of academic impact, for papers by Martine Ropert
Rankless by CCL
2026